TrialBMJ open2018

Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis.

Peter Connick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.